Jim Ross

Jim Ross's Title

Jim Ross holds the distinguished position of Board Member, leveraging his extensive expertise to guide strategic decisions and foster innovation. His leadership is augmented by a profound understanding of both the technical and business aspects of the life sciences industry, making him a vital asset to any organization he is part of.

Jim Ross's Education and Expertise

Jim Ross completed his PhD program in Neuroengineering at Georgia Tech, a prestigious achievement that underscores his deep knowledge in the intersection of biology and electronics. His expertise spans leading multidisciplinary teams to create user-friendly tools for life science instrumentation, medical diagnostics, and bioelectronic medicine. This unique blend of skills positions him at the forefront of innovation in these fields.

Jim Ross's Company

Jim Ross co-founded Axion Biosystems, a groundbreaking company known for its innovative contributions to life sciences. Under his leadership, the company introduced the Maestro system in 2011, the industry's first high-throughput micro electrode array (MEA) platform. Axion Biosystems' success culminated in its acquisition by Summa Equity in 2021, marking a significant milestone in the company's journey.

Jim Ross's Achievements

Jim Ross's career is decorated with numerous achievements, including the introduction of the Maestro system, which revolutionized high-throughput MEA platforms. His innovative work has earned him patents in electronically active cell culture assessment and non-invasive diagnostic and therapeutic technologies. In recognition of his contributions, he was inducted into the Young Alumni Engineering Hall of Fame at Georgia Tech, a testament to his impact on the field.

Jim Ross's Background

Jim Ross's background is rooted in a combination of rigorous academic training and practical, industry-shaping innovations. His work in merging electronics with biology to create cutting-edge tools has led to significant advancements in life science instrumentation and bioelectronic medicine. His ability to lead multidisciplinary teams has resulted in the development of user-friendly, impactful technologies that address critical needs in medical diagnostics and therapeutic applications.